VRTX
Vertex Pharmaceuticals Incorporated · Healthcare
SVP, Controller Paul M Silva sold $485K of Vertex Pharmaceuticals Incorporated
Sold$484,939
$231.03Price
2,099Shares
−10%Stake
What VRTX did after the filing
- The stock from Wed, Feb 5 close, $240.76
- −10.4%
- S&P 500, same days
- −27.7%
Measured over 30 trading days, to the Mar 19 close.
Traded Mon, Feb 3. Filed Wed, Feb 5, 11:52 AM ET, during the session. Returns use the Feb 5 close and the Mar 19 close. Not investment advice.